107 results on '"Schwitzer T"'
Search Results
2. Comparative analysis of anticholinergic burden scales to explain iatrogenic cognitive impairment and self-reported side effects in the euthymic phase of bipolar disorders: Results from the FACE-BD cohort
3. Impact spécifique du réentraînement à l’exercice sur les symptômes de dépression dans la broncho-pneumopathie chronique obstructive : expérience du Réseau insuffisance respiratoire de Lorraine
4. Clinical predictors of recurrences in bipolar disorders type 1 and 2: A FACE-BD longitudinal study
5. Evolution and characteristics of the use of valproate in women of childbearing age with bipolar disorder: Results from the FACE-BD cohort
6. Étude de la structure et de la fonction rétinienne chez les patients atteints de trouble dépressif sévère, de trouble bipolaire ou de schizophrénie : une revue de la littérature
7. Study of retinal structure and function in patients with major depressive disorder, bipolar disorder or schizophrenia: A review of the literature
8. Comparative analysis of anticholinergic burden scales to explain iatrogenic cognitive impairment and self-reported side effects in the euthymic phase of bipolar disorders: Results from the FACE-BD cohort
9. The effect of interactions between genetics and cannabis use on neurocognition. A review
10. Substance use disorders in bipolar patients with a painful expression
11. Electrophysiological markers for the identification of etiological processes of psycho-behavioral symptoms in the elderly
12. Retinal electrophysiological markers for precision medicine in psychiatry
13. Validation of a data collection set for the psychiatric, addiction, sleep and chronobiological assessments of patients with depression: A Delphi study for the SoPsy-depression French national cohort
14. Mindfulness-based relapse prevention for cannabis regular users: Preliminary outcomes of a randomized clinical trial
15. Assessment of neuropsychological impairments in regular cannabis users
16. Validation of a data collection set for the psychiatric, addiction, sleep and chronobiological assessments of patients with depression: A Delphi study for the SoPsy-depression French national cohort
17. Les outils de repérage pour les troubles de l’usage du cannabis et leur adaptation au DSM-5 : une revue de littérature
18. Free viewing exploration in schizophrenia: Review of evidence from laboratory settings to natural environment
19. Résultats préliminaires de l’étude combinée des propriétés locales et spatiales rétiniennes à l’aide de l’électrorétinogramme chez des patients présentant un épisode dépressif caractérisé unipolaire
20. Neuroretinal Dysfunctions in Regular Cannabis Users: An Impact of Cannabis on Retinal Neurotransmission?
21. Alterations in retinal processing in regular cannabis users
22. Retinal electrophysiological markers for precision medicine in psychiatry
23. P.1.j.026 The retinal pathways as a model to understand brain damages in cannabis users
24. Impaired retinal processing in regular cannabis users: Potential benefit of electroretinogram as a biomark
25. Electrophysiological markers for the identification of etiological processes of psycho-behavioral symptoms in the elderly
26. ElectroRetinoGraphy toward an exploration of the therapeutic potential of antidepressants in patients with major depressive disorder: A scoping review of the literature.
27. Commentary: Retinal electrophysiology in central nervous system disorders. A review of human and mouse studies.
28. Association between alcohol use and retinal dysfunctions in patients with alcohol use disorder: A window on GABA, glutamate, and dopamine modulations.
29. Commentary: Visual Hallucinations in Psychosis: The Curious Absence of the Primary Visual Cortex.
30. Crossed clinical features between eating disorders and types of bipolar disorder: Results from the FondaMental Advanced Centers of Expertise - Bipolar Disorder cohort.
31. Subsequent and simultaneous electrophysiological investigation of the retina and the visual cortex in neurodegenerative and psychiatric diseases: what are the forecasts for the medicine of tomorrow?
32. Association between retinal and cortical visual electrophysiological impairments in schizophrenia.
33. Clinical features and outcomes of COVID-19 patients hospitalized for psychiatric disorders: a French multi-centered prospective observational study.
34. Variations of retinal dysfunctions with the level of cannabis use in regular users: Toward a better understanding of cannabis use pathophysiology.
35. Retinal markers of therapeutic responses in major depressive disorder: Effects of antidepressants on retinal function.
36. Bipolar disorders and retinal electrophysiological markers (BiMAR): Study protocol for a comparison of electroretinogram measurements between subjects with bipolar disorder and a healthy control group.
37. Visual electrophysiology and neuropsychology in bipolar disorders: A review on current state and perspectives.
38. Retinal electroretinogram features can detect depression state and treatment response in adults: A machine learning approach.
39. A Reflection Upon the Contribution of Retinal and Cortical Electrophysiology to Time of Information Processing in Psychiatric Disorders.
40. Impaired P100 among regular cannabis users in response to magnocellular biased visual stimuli.
41. Retinal electrophysiology and transition to psychiatric disorders in subjects under the influence of cannabis.
42. Using retinal electrophysiology toward precision psychiatry.
43. Altered central vision and amacrine cells dysfunction as marker of hypodopaminergic activity in treated patients with schizophrenia.
44. Complete evaluation of retinal function in Major Depressive Disorder: From central slowdown to hyperactive periphery.
45. Retinal dysfunctions in a patient with a clinical high risk for psychosis and severe visual disturbances: A single case report.
46. Portable light therapy in the treatment of unipolar non-seasonal major depressive disorder: study protocol for the LUMIDEP randomised controlled trial.
47. Retinal structural changes in mood disorders: The optical coherence tomography to better understand physiopathology?
48. Oscillatory potentials abnormalities in regular cannabis users: Amacrine cells dysfunction as a marker of central dopaminergic modulation.
49. [Specific effect of exercise training on depression in COPD patients].
50. Delayed on- and off-retinal responses of cones pathways in regular cannabis users: An On-Off flash electroretinogram case-control study.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.